The rising threat of antibiotic and multidrug resistance in neonatal urinary tract infections
AMR and MDR in neonatal UTIs appear to be a serious problem. Treatment options in MDR UTIs remain limited, and it is particularly important to research on the pharmacokinetics and safety profiles of antimicrobials in children is essential to expand treatment options for pediatric populations worldwide.
Authors
- Emel Akbaş (ORCID: https://orcid.org/0000-0001-6589-7734)
- Nadide Melike Sav (ORCID: https://orcid.org/0000-0003-1520-6426)
- Mehmet Alı Sungur (ORCID: https://orcid.org/0000-0001-5380-0819)
- Fatih Kurt (ORCID: https://orcid.org/0000-0003-1975-6492)
- Mukaddes Kılıç Sağlam (ORCID: https://orcid.org/0000-0002-7231-5461)
- Kenan Kocabay (ORCID: https://orcid.org/0000-0002-4030-1145)
- Emine Yanaşoğlu
Institutions
- Düzce Üniversitesi (TR)
Publication Details
- Journal
- BMC Pediatrics
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1186/s12887-025-06210-6
- Citations
- 1
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35